These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 11784388)
1. Topiramate in drug-resistant complex partial status epilepticus. Reuber M; Evans J; Bamford JM Eur J Neurol; 2002 Jan; 9(1):111-2. PubMed ID: 11784388 [No Abstract] [Full Text] [Related]
2. Topiramate for bulimia nervosa in epilepsy. Knable M Am J Psychiatry; 2001 Feb; 158(2):322-3. PubMed ID: 11156822 [No Abstract] [Full Text] [Related]
3. Reversible language regression as an adverse effect of topiramate treatment in children. Gross-Tsur V; Shalev RS Neurology; 2004 Jan; 62(2):299-300. PubMed ID: 14745074 [TBL] [Abstract][Full Text] [Related]
4. Topiramate and status epilepticus: report of three cases. Bensalem MK; Fakhoury TA Epilepsy Behav; 2003 Dec; 4(6):757-60. PubMed ID: 14698713 [TBL] [Abstract][Full Text] [Related]
5. The use of topiramate in refractory status epilepticus. Towne AR; Garnett LK; Waterhouse EJ; Morton LD; DeLorenzo RJ Neurology; 2003 Jan; 60(2):332-4. PubMed ID: 12552056 [TBL] [Abstract][Full Text] [Related]
7. Oligohydrosis and hyperthermia: pilot study of a novel topiramate adverse effect. Ben-Zeev B; Watemberg N; Augarten A; Brand N; Yahav Y; Efrati O; Topper L; Blatt I J Child Neurol; 2003 Apr; 18(4):254-7. PubMed ID: 12760427 [TBL] [Abstract][Full Text] [Related]
8. The use of topiramate in refractory status epilepticus. Tarulli A; Drislane FW Neurology; 2004 Mar; 62(5):837. PubMed ID: 15007154 [No Abstract] [Full Text] [Related]